Clinical trial
D-Serine Treatment of Negative Symptoms and Cognitive Deficits in Schizophrenia
NCT00237809 · Yale University, Other · Completed
Key facts
| NCT number | NCT00237809 |
|---|---|
| Title | D-Serine Treatment of Negative Symptoms and Cognitive Deficits in Schizophrenia |
| Official title | D-Serine Treatment of Negative Symptoms and Cognitive Deficits in Schizophrenia |
| Lead sponsor | Yale University, Other |
| Collaborators | National Alliance for Research on Schizophrenia and Depression Donaghue Medical Research Foundation |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Schizophrenia, Schizoaffective Disorder |
| Intervention type | Behavioral, Drug |
| Interventions | D-serine, Cognitive Retraining (CRT), Placebo, Cognitive Retraining Placebo |
| Enrollment | 104 |
| Start date | Sep 1, 2002 |
| Primary completion | Dec 1, 2010 |
| Completion | Sep 1, 2012 |
| First posted | Oct 12, 2005 |
| Last update posted | May 10, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: